Idogen AB Financials

IDOGEN Stock  SEK 0.12  0.00  0.00%   
We strongly advise to harness Idogen AB fundamental analysis to find out if markets are presently mispricing the company. Simply put you can make use of it to find out if Idogen AB is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down and interpolate data for twenty-three available reported financial drivers for Idogen AB, which can be compared to its competitors. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Idogen AB to be traded at kr0.1188 in 90 days.
  
Understanding current and past Idogen AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Idogen AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Idogen AB's assets may result in an increase in income on the income statement.
Please note, the presentation of Idogen AB's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Idogen AB's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Idogen AB's management manipulating its earnings.
InstrumentSweden Stock View All
ExchangeStockholm Exchange
ISINSE0014428561
Business AddressMedicon Village, Lund,
IndustryBiotechnology
BenchmarkDow Jones Industrial
Websitewww.idogen.com
Phone46 4 62 75 63 30
CurrencySEK - Swedish Kronor
You should never invest in Idogen AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Idogen Stock, because this is throwing your money away. Analyzing the key information contained in Idogen AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Idogen AB Key Financial Ratios

Idogen AB's financial ratios allow both analysts and investors to convert raw data from Idogen AB's financial statements into concise, actionable information that can be used to evaluate the performance of Idogen AB over time and compare it to other companies across industries.

Idogen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Idogen AB's current stock value. Our valuation model uses many indicators to compare Idogen AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Idogen AB competition to find correlations between indicators driving Idogen AB's intrinsic value. More Info.
Idogen AB is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Idogen AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Idogen AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Idogen AB Systematic Risk

Idogen AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Idogen AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Idogen AB correlated with the market. If Beta is less than 0 Idogen AB generally moves in the opposite direction as compared to the market. If Idogen AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Idogen AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Idogen AB is generally in the same direction as the market. If Beta > 1 Idogen AB moves generally in the same direction as, but more than the movement of the benchmark.

Complementary Tools for Idogen Stock analysis

When running Idogen AB's price analysis, check to measure Idogen AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idogen AB is operating at the current time. Most of Idogen AB's value examination focuses on studying past and present price action to predict the probability of Idogen AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idogen AB's price. Additionally, you may evaluate how the addition of Idogen AB to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios